Form 15-12G Verona Pharma plc
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
| Commission File Number | 001-38067 |
| Verona Pharma plc | ||
| (Exact name of registrant as specified in its charter) | ||
|
3 More London Riverside London SE1 2RE United Kingdom +44 203 283 4200 | ||
| (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) | ||
| Ordinary Shares, nominal value £0.05 per share American Depositary Shares, each representing eight ordinary shares | ||
| (Title of each class of securities covered by this Form) | ||
| None | ||
| (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) | ||
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to
terminate or suspend the duty to file reports:
| Rule 12g-4(a)(1) | x | ||
| Rule 12g-4(a)(2) | ¨ | ||
| Rule 12h-3(b)(1)(i) | x | ||
| Rule 12h-3(b)(1)(ii) | ¨ | ||
| Rule 15d-6 | ¨ | ||
| Rule 15d-22(b) | ¨ |
| Approximate number of holders of record as of the certification or notice date | One (1) |
Pursuant to the requirements of the Securities Exchange Act of 1934 Verona Pharma plc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| VERONA PHARMA PLC |
| Date: | October 17, 2025 | By: | /s/ Benjamin Lucas | |
| Name: Benjamin Lucas Title: Principal Executive Officer and Director |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Happy Hemp Named in The Where Business 2026 CBD Gummies for Seniors Ranking
- Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
- Securitize Expands STAC, Tokenized AAA CLO Fund, to Solana
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share